Research groups
Lucinda Griffiths
BSc Econ (Hons.)
Trial Manager - Oncology Clinical Trial Office (OCTO)
Lucy joined the Department of Oncology in June 2011. Prior to this she worked for four years as a Trial Manager for a commercial research organisation, running multi centre studies in the UK and in China.
Oncology trials currently being managed:
LUD2015-005 - Phase 1/2 Study of anti-PD-L1 in Combination with Chemo(radio)therapy for Oesophageal Cancer
Oncology trials previously managed:
PEMBLA - Pembrolizumab in intermediate risk recurrent non-muscle invasive bladder cancer (NMIBC)
TARDOX - A Proof of Concept Study to Investigate the Feasibility of Targeted Release of Doxorubicin from Lyso-thermosensitive Liposomal (LTSL) Doxorubicin (ThermoDox®) Using Focused Ultrasound in Patients with Primary or Secondary Liver Tumours
6MP - A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours
CHOP-OR -A study of ofatumumab with CHOP chemotherapy for Richter's syndrome (CHOP-OR)
SONATINA - A Phase II Multi-Centre Randomised Controlled Study Of Nelfinavir Addition to Radiotherapy Treatment In Neo-Adjuvant Therapy for Rectal Cancer